Bank of Stockton’s Novartis NVS Stock Holding History

Bank of Stockton’s Portfolio NVS Stock Details NVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,974	Closed	-$210K	–	107
2016 Q3	$210K	Hold	2,974	–	–	0.1%	103
2016 Q2	$220K	Sell	2,974 -110	-4%	-$7.6K	0.12%	98
2016 Q1	$200K	Buy	3,084 +110	+4%	+$7.48K	0.11%	116
2015 Q4	$229K	Hold	2,974	–	–	0.13%	93
2015 Q3	$245K	Hold	2,974	–	–	0.15%	88
2015 Q2	$262K	Hold	2,974	–	–	0.15%	89
2015 Q1	$263K	Hold	2,974	–	–	0.14%	92
2014 Q4	$247K	Buy	2,974 +446	+18%	+$37K	0.14%	93
2014 Q3	$213K	Buy	2,528 +28	+1%	+$2.27K	0.13%	99
2014 Q2	$203K	Buy	+2,500	New	+$197K	0.12%	110

Other funds holding NVS

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BBHC

Brown Brothers Harriman & Co New York $18.6B AUM 15.81% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

MNA

Manning & Napier Advisors Fairport, New York $7.09B AUM 17.35% 1-Year Est. Return

Bank of Stockton's NVS Position: Q4 2016 in Review

Bank of Stockton sold out of Novartis (NVS) in Q4 2016, closing a stake of 2,974 shares — an estimated $210K sold.

Bank of Stockton first reported a position in NVS in Q2 2014 and held it in 10 quarters. The position peaked at $263K in Q1 2015. 905 funds tracked by Wall St. Rank hold NVS as of Q4 2016.

Bank of Stockton reported no remaining Novartis position as of Q4 2016 after selling out during the quarter.
Bank of Stockton sold 2,974 Novartis shares in Q4 2016, an estimated $210K.
Bank of Stockton first reported a position in Novartis in Q2 2014 and held it in 10 quarters.
Bank of Stockton's Novartis position peaked at $263K in Q1 2015.
905 funds tracked by Wall St. Rank held Novartis as of Q4 2016.

Based on Bank of Stockton's 13F filing for Q4 2016, filed 18 Jan 2017.